Cancer affecting breast, ovary, skin (SC), endometrium (EC), pancreas (PC) and prostate (PrC) accounted for 91.2% of all tumors registered in BRCA1/2 patients and 93.7% among HR-BRCA-negative and low risk cases. The gene discussed is BRCA1; the disease is cancer.